Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Description
Depression and cognitive disorders are severe conditions with complex and not-fully understood etiology. Unfortunately, the COVID-19 pandemic dramatically increased the prevalence of both conditions. Since the current treatments are inadequate in
